How 23andMe went from a $6 billion valuation to trading for pennies
Listen now
Description
Cofounder and CEO of 23andMe, Anne Wojcicki, wants to take the public company private. Founded in 2006, the DNA-testing startup was valued at $6 billion in 2021. Now, it’s trading for less than a dollar. So what happened? ‘Fast Company’ senior writer Ainsley Harris breaks down 23andMe’s history, and why the company faces an uncertain future. Also, actor Edward Norton chats with ‘Fast Company’ staff writer David Salazar about his startup, Zeck. After decades of serving on nonprofit and corporate boards, as well as working with boards as a founder, Norton realized that modern, streamlined tools could vastly improve boardroom communication. His company aims to change the dynamics of boards and company management by reducing repetitive tasks and facilitating better collaboration. And heads up, our show will be shifting to publish on Thursdays starting August 22!
More Episodes
There’s a new social media giant on the scene. After Donald Trump’s Elon Musk–assisted reelection, Blueksy’s user base ballooned. It now has over 20 million users and is the No. 1 app in the App Store. Yaz and Josh sit down with Bluesky COO Rose Wang to discuss Bluesky’s core tenets, what the...
Published 11/21/24
In this custom episode from FastCo Works and Medtronic, Kathleen Koch chats with Medtronic chairman and CEO Geoff Martha and chief technology and innovation officer Ken Washington. New medical devices and therapies, including those powered by data, AI, and robotics, are pushing the boundaries of...
Published 11/20/24
Published 11/20/24